[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356825-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-356825-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","regulating-the-dormancy-of-cancer-stem-cells-a-novel-approach-to-preventing-cancer-relapse","Regulating the dormancy of cancer stem cells: a novel approach to preventing cancer relapse","","Dormant cancer stem cells (CSCs) are implicated as a key driver of drug resistance, metastasis, and later recurrence in malignant tumors, yet their biological mechanisms require deeper clarification. The review describes dormant CSCs as cycling in the G0 phase with enhanced autophagy, genomic stability, and high plasticity, and summarizes newly identified dormant-specific markers (e.g., p27, CD13, QSOX1, Survivin, GPD1, BEX2). It also addresses epigenetic control of quiescent versus proliferative transitions and highlights clinical strategies aimed at maintaining dormancy to curb tumor relapse and metastatic spread.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/regulating-the-dormancy-of-cancer-stem-cells-a-novel-approach-to-preventing-cancer-relapse/356825/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/regulating-the-dormancy-of-cancer-stem-cells-a-novel-approach-to-preventing-cancer-relapse/356825.png","ImageObject",300,407,{"name":42,"@type":43},"Terk","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What biological features define dormant cancer stem cells?","Question",{"text":63,"@type":64},"Dormant CSCs reside in the G0 phase and show enhanced autophagic activity, stable genomic structure, and strong plasticity.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do chemotherapy and the tumor microenvironment affect dormant CSCs?",{"text":68,"@type":64},"Chemotherapy can awaken dormant CSCs, which can promote recurrence and metastasis. Dormant CSCs also communicate with fibroblasts, mesenchymal stem cells, and immune cells within the tumor microenvironment.",{"name":70,"@type":61,"acceptedAnswer":71},"Why is maintaining CSC dormancy considered clinically important?",{"text":72,"@type":64},"Keeping CSCs in a dormant state may help prevent tumor recurrence and metastasis, addressing a major cause of cancer mortality.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},356825,1790168882,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099525198933,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","[www.nature.com/cddis](www.nature.com/cddis)  \nREVIEW ARTICLE OPEN   \nRegulating the dormancy of cancer stem cells: a novel approach to preventing cancer relapse  \nQian Wang 1,4, Ning Liang 2,4, Xiongchao Fang1,4, Tao Yang3,4, Xianli He 1 ✉, Gang Wang 1 ✉ and Nan Wang 1 ✉  \n© The Author(s) 2026  \n|  |  |  |\n| --- | --- | --- |\n|  | Dormant cancer stem cells (CSCs) are the root cause of the drug resistance and metastatic processes of malignant tumors, but an indepth analysis of their biological mechanisms is needed. Dormant CSCs are in the G0 phase of the cell cycle and are characterized by enhanced autophagic activity, a stable genomic structure and strong plasticity. Recently, several new speciﬁc markers of dormant CSCs, such as p27, CD13, QSOX1, Survivin, GPD1 and BEX2, have been identiﬁed, which offer hope for targeted therapy. In addition, epigenetic modiﬁcations such as DNA methylation and histone modiﬁcations have been reported to regulate the transition between the quiescent and proliferative states of dormant CSCs. From a clinical perspective, keeping cancer stem cells in a dormant state is helpful for preventing tumor recurrence and metastasis. To this end, clarifying the potential mechanisms and molecular regulation of cancer stem cell dormancy is vital. Here, in this review, we examine recent signiﬁcant ﬁndings regarding tumor stem cell dormancy in both experimental and human disease models, emphasizing the underlying molecular mechanisms, regulatory processes, |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| experimental models, and prospective research directions aimed at advancing this ﬁeld and enhancing clinical translation. |  |  |\n|  | Cell Death and Disease (2026)17:497; [https://doi.org/10.1038/s41419-026-08707-z](https://doi.org/10.1038/s41419-026-08707-z) |  |\n|  |  |  |\n\nFACTS  \n● The dormancy mechanism of tumor cells has been widely studied, but the dormancy mechanism of cancer stem cells (CSCs) has not been fully elucidated.  \n● Chemotherapy can awaken dormant cancer stem cells (dormant CSCs), thereby promoting tumor recurrence and metastasis.  \n● Dormant CSCs closely communicate with ﬁbroblasts, mesenchymal stem cells and immune cells in the tumor microenvironment.  \n● Keeping CSCs in a dormant state may help prevent the recurrence and metastasis of tumors.  \nOPEN QUESTIONS  \n● What is the mechanism by which cancer stem cells maintain dormancy?  \n● How can the resistance of dormant CSCs to chemotherapy, radiotherapy, and targeted drugs be overcome?  \n● How can real-time tracking technology for dormant CSCs be developed to facilitate therapeutic effect evaluation?  \nINTRODUCTION  \nMetastasis is the leading cause of cancer death [1–4] . The concept of cancer recurrence can be traced back to the ﬁrst century, as  \nevidenced by Celsus’s ﬁrst observation that “even if a scar is formed after excision, the disease will still recur and lead to death”(Fig. 1) [5] . In 1934, Rupert Willis discovered that distant metastases could occur in patients without local recurrence, suggesting that tumor cells might remain dormant in metastatic tissue[6] . In 1954, Jeffrey Hadﬁeld advanced the concept that dormant cancer cells in distant metastases undergo a phase of“temporary mitotic arrest” [7] . In fact, cancer cell dormancy is a recognized phenomenon in many common solid cancers, including breast, lung, colon, melanoma, and leukemia [8–13] . Clinically, more than 25% of breast cancer patients experience long-term recurrence following treatment, a phenomenon referred to as dormant metastasis [14, 15] . In 1972, Judah Folkman introduced the concept of “tumor mass dormancy”, which describes a state in which a tumor remains at a low but undetectable steady-state level because of a balance between cell growth and death. Notably, the concept of “tumor mass dormancy” is signiﬁcantly different from that of “dormant cancer cells”, as the latter do not proliferate [16] .  ","cbCaiaIdL73f8MMD","https://ap.wps.com/l/cbCaiaIdL73f8MMD","pdf",2570523,17,"English","# Introduction\n## Cancer cell dormancy and recurrence\n## Cancer stem cells and dormant CSCs\n# Facts and Open Questions\n## Key facts\n## Open questions","[{\"question\":\"What biological features define dormant cancer stem cells?\",\"answer\":\"Dormant CSCs reside in the G0 phase and show enhanced autophagic activity, stable genomic structure, and strong plasticity.\"},{\"question\":\"How do chemotherapy and the tumor microenvironment affect dormant CSCs?\",\"answer\":\"Chemotherapy can awaken dormant CSCs, which can promote recurrence and metastasis. Dormant CSCs also communicate with fibroblasts, mesenchymal stem cells, and immune cells within the tumor microenvironment.\"},{\"question\":\"Why is maintaining CSC dormancy considered clinically important?\",\"answer\":\"Keeping CSCs in a dormant state may help prevent tumor recurrence and metastasis, addressing a major cause of cancer mortality.\"}]","Regulating the dormancy of cancer stem cells: a novel approach to preventing cancer relapse | PDF",1790127505,43,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d0785b24cdb37e8165c14d9c816a4aa9.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/96ef1a6ea12f214907d2c4fa09ba36d8.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1e238cb3e1dc9e38a54bf62cdcd88eea.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1128bd5408b0004cc1fd8aef009f26b2.webp",980,1301]